VU Research Portal
Biomarkers and Thiopurines in IBD
Meijer, B.
2017
document version
Publisher's PDF, also known as Version of record
Link to publication in VU Research Portal
citation for published version (APA)
Meijer, B. (2017). Biomarkers and Thiopurines in IBD: when two worlds collide.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal ? Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
E-mail address:
Anna Ashcroft, BSc
Christchurch Hospital, University of Otago, Christchurch, New Zealand
Hans Blokzijl, MD, PhD
University Medical Center Groningen, Rijks University Groningen, Groningen, The Netherlands
Professor Gerd Bouma, MD, PhD
VU University Medical Center, VU University, Amsterdam, The Netherlands
Laura Burgess, BSc
Christchurch Hospital, University of Otago, Christchurch, New Zealand
Minneke J Coenraad, MD, PhD
Leiden University Medical Center, Leiden University, Leiden, The Netherlands
Professor Andrew S Day, MBChB, PhD, FRACP, AGAF
Christchurch Hospital, University of Otago, Christchurch, New Zealand
Nanne K H de Boer, MD, PhD
VU University Medical Center, VU University, Amsterdam, The Netherlands
Professor Robert A de Man, MD, PhD
Erasmus University Medical Center, Erasmus University, Rotterdam, The Netherlands
Luc J J Derijks, PharmD, PhD
Máxima Medical Center, Veldhoven, The Netherlands
Professor Gerard Dijkstra, MD, PhD
University Medical Center Groningen, Rijks University Groningen, Groningen, The Netherlands
James D Falvey, MBChB, PhD
Christchurch Hospital, University of Otago, Christchurch, New Zealand
Professor Christopher M A Frampton, BSc, PhD
Christchurch Hospital, University of Otago, Christchurch, New Zealand
Professor Richard B Gearry, MBChB, FRACP, PhD
Christchurch Hospital, University of Otago, Christchurch, New Zealand
Frank Hoentjen, MD, PhD
Radboud University Medical Center, Radboud University, Nijmegen, The Netherlands
Teagan Hoskin, BSc
Christchurch Hospital, University of Otago, Christchurch, New Zealand
Jacqui I Keenan, MApplSci, PhD
Christchurch Hospital, University of Otago, Christchurch, New Zealand
Jan-Kees Kneppelhout, MD
St. Anna Hospital, Geldrop, The Netherlands
Joany E Kreijne, MD
Erasmus University Medical Center, Erasmus University, Rotterdam, The Netherlands
Niek N W Leijte, MD
VU University Medical Center, VU University, Amsterdam, The Netherlands
Ronald K Linskens, MD, PhD
St. Anna Hospital, Geldrop, The Netherlands
Professor Chris J J Mulder, MD, PhD
VU University Medical Center, VU University, Amsterdam, The Netherlands
Bas Oldenburg, MD, PhD
University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
Professor Godefridus J Peters, MD, PhD
VU University Medical Center, VU University, Amsterdam, The Netherlands
Cyriel Y Ponsioen, MD, PhD
Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Dewkoemar Ramsoekh, MD, PhD
VU University Medical Center, VU University, Amsterdam, The Netherlands
Melek Simsek, MD
VU University Medical Center, VU University, Amsterdam, The Netherlands
Professor Catherine Stedman, MBChB, FRACP, PhD
Christchurch Hospital, University of Otago, Christchurch, New Zealand
Adriaan A van Bodegraven, MD, PhD
VU University Medical Center, VU University, Amsterdam, The Netherlands Zuyderland Medical Center, Sittard-Geleen, The Netherlands
Andrea E van der Meulen, MD, PhD
Leiden University Medical Center, Leiden University, Leiden, The Netherlands
Professor C Janneke van der Woude, MD, PhD
Erasmus University Medical Center, Erasmus University, Rotterdam, The Netherlands
Remco van Egmond, MD
VU University Medical Center, VU University, Amsterdam, The Netherlands
Charlotte K van Everdingen, MD
VU University Medical Center, VU University, Amsterdam, The Netherlands Christchurch Hospital, University of Otago, Christchurch, New Zealand
Sofia A W van Moorsel, PharmD
Zuyderland Medical Center, Sittard-Geleen, The Netherlands
Carin M J van Nieuwkerk, MD, PhD
VU University Medical Center, VU University, Amsterdam, The Netherlands
Abraham J Wilhelm, PharmD, PhD
VU University Medical Center, VU University, Amsterdam, The Netherlands
Dion Wintjens, MD
Maastricht University Medical Center, Maastricht University, Maastricht, The Netherlands
Dennis R Wong, PharmD, PhD
Meijer B, Gearry RB, Day AS.
The role of S100A12 as a systemic marker of inflammation.
International Journal of Inflammation, 2012. Meijer B, Gearry RB, Day AS.
S100A12 in EDTA plasma - a cautionary tale.
Journal of Crohn’s and Colitis, 2012.
Meijer B, Hoskin T, Ashcroft A, Burgess L, Keenan JI, Falvey JD, Gearry RB, Day AS.
Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD.
Journal of Crohn’s and Colitis, 2013.
Falvey JD, Hoskin T, Meijer B, Ashcroft A, Walmsley R, Day AS, Gearry RB.
Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.
Inflammatory Bowel Diseases, 2015. Meijer B, Bouma G, de Boer NKH.
Optimize thiopurine therapy in autoimmune hepatitis.
Clinical Gastroenterology and Hepatology, 2016.
Meijer B, Seinen ML, Leijte N, Mulder CJJ, van Bodegraven AA, de Boer NKH.
Clinical Value of Mercaptopurine after Failing Azathioprine Therapy in Patients with Inflammatory Bowel Disease.
Therapeutic Drug Monitoring, 2016. Meijer B, Mulder CJJ, de Boer NKH.
NUDT15: a novel player in thiopurine metabolism.
Journal of Gastrointestinal and Liver Diseases, 2016.
Dujardin RWG, Meijer B, de Boer NKH, D’Haens GRAM, Löwenberg M.
Usefulness of MCV as surrogate marker for monitoring thiopurine treatment in IBD.
European Journal of Gastroenterology & Hepatology, 2016.
Meijer B, Mulder CJJ, Peters GJ, van Bodegraven AA, de Boer NKH.
The efficacy of Thioguanine Treatment in IBD: a Systematic Review.
World Journal of Gastroenterology, 2016.
Meijer B*, Simsek M*, Blokzijl H, de Man RA, Coenraad MJ, Dijkstra G, van Nieuwkerk CMJ, Mulder CJJ, de Boer NKH.
Nodular Regenerative Hyperplasia Rarely Leads To Liver Transplantation: a 20-year retrospective study in all Dutch liver transplant units.
United European Gastroenterology Journal, 2016.
Meijer B, Kreijne JE, van Moorsel SAW, Derijks LJJ, Bouma G, Mulder CJJ, Wong DR, van der Woude CJ, van Bodegraven AA, de Boer NKH.
6-methylmercaptopurine induced leukocytopenia during thiopurine therapy in IBD patients.
Journal of Gastroenterology and Hepatology, 2016. Meijer B, Mulder CJJ, van Bodegraven AA, de Boer NKH.
How I treat my IBD patients with thiopurines.
World Journal of Gastrointestinal Pharmacology and Therapeutics, 2016.
Meijer B, Seinen ML, van Egmond R, Bouma G, Mulder CJJ, van Bodegraven AA, de Boer NKH.
Optimizing thiopurine therapy in inflammatory bowel disease amongst two real-life intercept cohorts: effect of allopurinol co-medication?
Inflammatory Bowel Diseases, 2017.
Meijer B, Wilhelm AJ, Bouma G, Mulder CJJ, van Bodegraven AA, de Boer NKH.
Pharmacology of thiopurine therapy in inflammatory bowel disease and complete blood count outcomes: a 5-year database study.
Therapeutic Drug Monitoring, 2017. Meijer B, de Boer NKH.
Do not forget to culture.
Digestive and Liver Diseases, 2017. Meijer B, de Boer NKH.
All thiopurines are equal but some thiopurines are more equal than others.
JAMA Oncology, 2017. Meijer B, de Boer NKH.
Accelerating with the brakes on?
Meijer B*, van Everdingen CK*, Ramsoekh DR, Stedman C, Frampton CM, Mulder CJJ, Bouma G, de Boer NKH, Gearry RB.
Transient elastography to detect liver fibrosis in patients with inflammatory bowel disease.
Submitted
Meijer B, Mulder CJJ, Ponsioen CY, van der Woude CJ, van der Meulen AE, Wintjens D, Dijkstra G, Hoentjen F, Oldenburg B, van Bodegraven AA, de Boer NKH, on behalf of the Dutch Initiative on Crohn and Colitis and Parelsnoer Institute.
Methotrexate and thioguanine rescue therapy for conventional thiopurine failing ulcerative colitis patients: a multi-center database study on tolerability and effectiveness.
Submitted
Meijer B, Seinen ML, Hosman T, Linskens RK, Kneppelhout JC, Peters GJ, Mulder CJJ, van Bodegraven AA, de Boer NKH.
Inter-individual variability of xanthine oxidase activity in IBD patients.
Submitted
Simsek M, Meijer B, Mulder CJJ, van Bodegraven AA, de Boer NKH.
Analytical pitfalls of therapeutic drug monitoring of thiopurines in inflammatory bowel disease patients.
Therapeutic Drug Monitoring, 2017.
Simsek M, Meijer B, van Bodegraven AA, de Boer NKH, Mulder CJJ.
Finding hidden treasures in old drugs: The importance of licensing generic drugs and its challenges
Drug Discovery Today, 2017.
de Boer NKH, Peyrin-Biroulet L, Jharap B, Sanderson JD, Meijer B, Atreya I, Barclay ML, Colombel J-F, Lopez A, Beaugerie L, Marinaki AM, van Bodegraven AA, Neurath MF.
Thiopurines in Inflammatory Bowel Disease: a state-of-the-art review.
Submitted
Simsek M*, Meijer B*, Ramsoekh D, Bouma G, van der Wouden EJ, den Hartog B, de Vries AC, Hoentjen F, Dijkstra G, de Boer SY, Jansen JM, van der Meulen AE, Beukers R, Brink MA, Steinhauser T, Oldenburg B, Gilissen LP, Naber TH, Verhagen MA, de Boer NKH, Mulder CJJ.
Natural course of nodular regenerative hyperplasia in thiopurine treated inflammatory bowel disease patients.
